Despite these positive benefits, the adoption of these initiatives has been slow and there are still barriers to success. In many instances, there are not enough people to process the mass amount of information these data driven sciences create or critical patient data is either incomplete or inaccurate because of a reliance on digital tools for data collection.

Precision Medicine is still a developing medical science, but it has the potential to add lifesaving initiatives to many aspects of the pharma field. If genetic testing and biomarker indication techniques are used properly and on the right people, a massive impact can be made in the area of disease prevention.

• Analyze how novel, innovative, and creative data driven medical systems are being developed to better patient outcomes and payer satisfaction
• Overcome common barriers to precision medicine acceptance and increase widespread adoption throughout your medical and commercial enterprise
• Understand how to integrate new, data driven sciences that increase HCP efficiency and improved patient outcomes on your brand therapeutic
• Review the latest achievements from top academic researchers and the impact these research studies will have on the future of precision medicine in the pharma business model
• Examine new patient care models and how best to convey their importance to both payer and HCP
• Build on knowledge of essential biomarker and geno-type based therapies and how best to apply them to current care models
• Gain an understanding of the future of pharmacogenomics and pharmacogenetics testing and the advantages to utilizing this advancing medical science within precision medicine